Graeme Bell Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Graeme Bell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Graeme Bell. Graeme Bell is Executive VP and CFO in Anacor Pharmaceuticals, Inc. ($ANAC) and EVP, Chief Financial Officer in Intellia Therapeutics, Inc. ($NTLA).
Latest Insider Trading Transactions of Graeme Bell
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2018 | NTLA | Intellia Therapeut ... | Bell Graeme | EVP, Chief Financia ... | Option Exercise | M | 13.48 | 8,000 | 107,840 | 202,000 | |
| Mar 30 2018 | NTLA | Intellia Therapeut ... | Bell Graeme | EVP, Chief Financia ... | Buy | M | 13.48 | 8,000 | 107,840 | 21,400 | 13.4 K to 21.4 K (+59.70 %) |
| Jan 29 2018 | NTLA | Intellia Therapeut ... | Bell Graeme | EVP, Chief Financia ... | Option Exercise | A | 22.78 | 25,000 | 569,500 | 25,000 | |
| Dec 14 2017 | NTLA | Intellia Therapeut ... | Bell Graeme | EVP, Chief Financia ... | Option Exercise | A | 18.30 | 72,500 | 1,326,388 | 72,500 | |
| Nov 03 2017 | NTLA | Intellia Therapeut ... | Bell Graeme | EVP, Chief Financia ... | Grant | A | 22.04 | 5,000 | 110,217 | 13,400 | 8.4 K to 13.4 K (+59.52 %) |
| Jun 05 2017 | NTLA | Intellia Therapeut ... | Bell Graeme | EVP, Chief Financia ... | Grant | A | 12.37 | 8,400 | 103,938 | 8,400 | 0 to 8.4 K |
| Jan 05 2017 | NTLA | Intellia Therapeut ... | Bell Graeme | EVP, Chief Financia ... | Option Exercise | A | 13.48 | 210,000 | 2,830,800 | 210,000 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 78.91 | 25,299 | 1,996,344 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 78.91 | 25,299 | 1,996,344 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 69.34 | 28,793 | 1,996,507 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 69.34 | 28,793 | 1,996,507 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 4,004 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 4,004 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 8,008 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | D | 0.00 | 8,008 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Sell | D | 99.25 | 10,488 | 1,040,934 | 0 | 10.5 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Sell | D | 99.25 | 10,488 | 1,040,934 | 0 | 10.5 K to 0 (-100.00 %) |
| Jun 03 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Sell | S | 99.28 | 751 | 74,559 | 10,255 | 11 K to 10.3 K (-6.82 %) |
| Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 78.91 | 25,299 | 1,996,344 | 25,299 | |
| Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Grant | A | 0.00 | 5,000 | 0 | 11,006 | 6 K to 11 K (+83.25 %) |
| Jun 03 2015 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 0.00 | 4,004 | 0 | 4,004 | |
| Jun 03 2015 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 0.00 | 8,008 | 0 | 8,008 | |
| Jun 03 2015 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Option Exercise | A | 69.34 | 28,793 | 1,996,507 | 28,793 | |
| Jun 03 2015 | ANAC | Anacor Pharmaceuti ... | Bell Graeme | Executive VP and CF ... | Grant | A | 0.00 | 6,006 | 0 | 6,006 | 0 to 6 K |
Page: 1